Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines
Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines. // Vaccine: X. – URL: https://www.sciencedirect.com/science/article/pii/S259013622600152X?dgcid=rss_sd_all
Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines. Vaccine: X. https://www.sciencedirect.com/science/article/pii/S259013622600152X?dgcid=rss_sd_all
“Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines.” Vaccine: X.
@article{article833,
title = {Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines},
journal = {Vaccine: X},
url = {https://www.sciencedirect.com/science/article/pii/S259013622600152X?dgcid=rss_sd_all}
}